Prevalence and genetic analysis of thalassemia in childbearing age population of Hainan, The Free Trade Island in Southern China
- PMID: 35119136
- PMCID: PMC8906206
- DOI: 10.1002/jcla.24260
Prevalence and genetic analysis of thalassemia in childbearing age population of Hainan, The Free Trade Island in Southern China
Abstract
Background: Hainan has one of the high incidences of thalassemia in China, but the epidemiological data in the whole province has not been reported yet. The objective of our study was to reveal the true prevalence and molecular mutation spectrum of thalassemia in the population of Hainan who are of childbearing age.
Methods: We screened 166,936 individuals from 19 cities and counties in Hainan by hematological parameters analysis, and further conducted genetic analysis for individuals whose MCV was less than 82fL.
Results: In total, 21,619 (12.95%) subjects were diagnosed as thalassemia carriers or patients. The overall prevalence of α-thalassemia, β-thalassemia, and α+β-thalassemia were 10.39%, 1.38%, and 1.18%, respectively. Eleven α-thalassemia mutations and sixteen β-thalassemia mutations were identified. The high-frequent genotypes of α-thalassemia were -α3.7 /αα (19.70%), -α4.2 /αα (19.39%), αα/--SEA (15.60%), αWS α/αα (9.24%), and -α3.7 /-α4.2 (8.90%), and those of β-thalassemia were βCD41/42(-TTCT) /βN (58.92%), β-28(A>G) /βN (16.05%), βIVS-Ⅱ-654(C>T) /βN (8.42%), βCD71/72(+A) /βN (6.03%), βCD17(A>T) /βN (5.47%), and βCD26 (GAG>AAG) /βN (2.69%). In addition, the frequencies and hematological profiles of many rare mutations of α- [Fusion, HKαα, αααanti4.2 , IVS-II-55 (T>G), IVS-II-119 (-G,+CTCGGCCC)] and β-globin genes [-50 (G>A), IVS-Ⅱ-81 (C>T)] in Hainan were reported for the first time.
Conclusion: Our study revealed the high prevalence and extensive molecular spectrum of thalassemia in childbearing age population of Hainan, suggesting thalassemia in Hainan ranks second in prevalence among all regions in China. The findings will be useful for genetic counseling and prevention of thalassemia.
Keywords: childbearing age; molecular spectrum; prevalence; thalassemia.
© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Conflict of interest statement
Meifang Xiao received the funding from the Open Foundation of NHC Key Laboratory of Tropical Disease Control, Hainan Medical University, and Hainan Natural Science Foundation. The remaining authors have no relevant conflicts of interest to disclose, and the manuscript is approved by all authors for publication.
References
-
- Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155‐167. - PubMed
-
- Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193‐211. - PubMed
-
- Piel FB, Weatherall DJ. The alpha‐thalassemias. N Engl J Med. 2014;371(20):1908‐1916. - PubMed
-
- Origa R. beta‐Thalassemia. Genet Med. 2017;19(6):609‐619. - PubMed
-
- Khandros E, Kwiatkowski JL. Beta thalassemia: monitoring and new treatment approaches. Hematol Oncol Clin North Am. 2019;33(3):339‐353. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
